High-Throughput Screening and Molecular Dynamics Simulation of Natural Product-like Compounds against Alzheimer’s Disease through Multitarget Approach
Alzheimer’s disease (AD) is a progressive neurological disorder that affects 50 million people. Despite this, only two classes of medication have been approved by the FDA. Therefore, we have planned to develop therapeutics by multitarget approach. We have explored the library of 2029 natural product...
Main Authors: | Danish Iqbal, Md Tabish Rehman, Abdulaziz Bin Dukhyil, Syed Mohd Danish Rizvi, Mohamed F. Al Ajmi, Bader Mohammed Alshehri, Saeed Banawas, M. Salman Khan, Wael Alturaiki, Mohammed Alsaweed |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/9/937 |
Similar Items
-
A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis
by: Juan Francisco Sánchez-Tejeda, et al.
Published: (2020-03-01) -
Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer’s disease
by: Wen-Yu Wu, et al.
Published: (2017-01-01) -
Multitarget therapeutic strategies for Alzheimer’s disease
by: Mostafa M. Ibrahim, et al.
Published: (2019-01-01) -
Study of new propargylamine and donepezil-derived compounds as multitarget agents for the treatment of alzheimer’s disease
by: Bolea Tomás, Irene
Published: (2011) -
An Efficient Multi-Path Multitarget Tracking Algorithm for Over-The-Horizon Radar
by: Yuan Huang, et al.
Published: (2019-03-01)